Argos Therapeutics higher after pricing IPO below range

|About: Argos Therapeutics, Inc. (ARGS)|By:, SA News Editor

After pricing its 5.625M-share IPO at $8 (below a range of $13-$15), Argos Therapeutics (ARGS) opened at $8.90 and is currently at $8.69, up 9%.

The cancer/infectious disease drug developer has a market cap of $165M.

Prospectus, IPO preview